EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

41 hedge funds and large institutions have $55.2M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.87M
2
+$2.2M
3
+$1.89M
4
CCM
CAAS Capital Management
New York
+$935K
5
GF
Gabelli Funds
New York
+$711K

Top Sellers

1
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.05M
2
$4.87M
3
$4.84M
4
$3.15M
5
$2.93M
6
$2.9M
7
$2.67M
8
$2.42M
9
$2.21M
10
$1.95M
11
$1.93M
12
$1.45M
13
$1.45M
14
$1.43M
15
$1.26M
16
$1.22M
17
$1.21M
18
$1.21M
19
$971K
20
$969K
21
$967K
22
$967K
23
$935K
24
$711K
25
$637K
1
2